SUMMIT THERAPEUTICS INC. (SMMT)

(10% Negative) SUMMIT THERAPEUTICS INC. (SMMT) Announces Delay in Progress Trials for clinical studies globally Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment